The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.SGEN 15.43%
Market Cap 11 Billion
Seattle Genetics is a biotech firm focused on the development of monoclonal antibody-based therapies. The company's lead product, Adcetris, has received approval for advanced frontline, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. The company has several other early-stage programs in trials. Seattle Genetics also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies.
EPS -0.49 P/E Ratio 0.00
Previous Tue, Jul 16, 2019
Latest Tue, Oct 29, 2019 (In 7 days)
Pay Date --
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.